摘要
为了提高对乳腺癌新辅助内分泌治疗的认识,调整传统观念,笔者回顾性阅读研究了综合文献资料,所得结论要点为:乳腺癌新辅助内分泌治疗是最近年才提出的一种治疗乳腺癌的辅助治疗手段,有助于肿瘤的降期和局部控制,且副反应较轻,临床应用前景广阔。
出处
《中国普通外科杂志》
CAS
CSCD
2007年第11期1102-1104,共3页
China Journal of General Surgery
参考文献27
-
1Jordan VC. Tamoxifen: a most unlikely pioneering medicine [ J ] . Nat Rev Drug Discov, 2003,2 ( 3 ) : 205 -213.
-
2Gradishar W J. Recently initiated studies : neoadjuvant treatments in next century [ J ]. Semi Oncol, 1999,26 ( 1 suppl3) :26 -29.
-
3Mauriac L, MacGrogan G, Avril A, et al. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 : a unicentre randomised trial with a 124-month follow up [ J ] . Ann Oncol,1999,10(1) :47 -52.
-
4霍彦平,高峰,吕晶.绝经后乳腺癌术前内分泌治疗的近期疗效[J].新医学,2003,34(12):736-737. 被引量:3
-
5Holt PM, Valero V, Buzdar AU, et al. Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with Severe comorbid conditions using tamoxifen as the primary therapy [ J ]. Cancer, 2000, 88 ( 9 ) : 2054 - 2060.
-
6丁小文,郑树.乳腺癌新辅助内分泌治疗研究进展[J].国际肿瘤学杂志,2006,33(1):38-41. 被引量:12
-
7Mauriac L, Debled M, Durand M, et al. Neoadjuvant tamoxifen for hormone-sensitive non-metastatic breast carcinoma in early postmenopausal women [ J ]. Ann Onco1 , 2002,13 ( 1 ) : 193 - 198.
-
8Gil Gil M J, Bamadas A, Cireral L, et al. Primary hormonal therapy with exemestane in patients with breast tumors > 3 cm in diameter : results of a Spanish muhicenter phase II trial [ J ]. Proc Am Soc Clin OnsoI, 2004,23(1) :27 -31.
-
9Nehmat Houssami, Jack Cuzick, J Michael Dixon. The prevention, detection, and management of breast cancer [ J ]. The Medical Journal of Australia,2006,184 (5):230 - 234.
-
10Eiermann W , Paepke S, Appfelstaedt L, et 02. Preoperative treatment of postmenopausal breast cancer patients with letmzole: a randomized double-blind multicenter study [ J ] . Ann Oncol, 2001, 12 ( 11 ) : 1527 - 1532.
二级参考文献30
-
1Dixon JM, Anderson TJ, Miller WR. Neoadjuvant endocrine therapy of breast cancer : a surgical perspective. Eur J Cancer, 2002,38 ( 17 ) :2214-2221.
-
2Hoff PM,Valero V, Buzdar AU, et al. Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy. Cancer,2000,88(9):2054-2060.
-
3Dixon JM, Love CD, Bellamy CO, et al. Izetrozole as primary medical therapy for locally advanced and large operable breast cancer. Breast Cancer Res Treat,2001,66 ( 3 ) : 191-199.
-
4Eiermann W, Paepke S, Appfelstaedt J,et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized doable-blind multicen|er study. Ann Oncol, 2001,12 ( 11 ) : 1527-1532.
-
5Ellis MJ, Coop A, Singh B,et. al. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB- 1 and/or ErbB-2 positive, estrogen receptor positive primary breast cancer: evidence from a phase Ⅲ randomized trial. J Clin Oncol,2001,19(18) :3808-3816.
-
6Milla Santos A, Milla L, Cairo N, et al. Anastrozole as neoadjuvant therapy for patients with hormone- dependent, locally- advanced breast cancer. Anticancer Res,2004,24 (2C) : 1315-1318.
-
7Dixon JM, Renshaw L, Bellamy C, et al. The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study. Clin Cancer Res,2000,6(6) :2229-2235.
-
8Miller WR, Dixon JM. Endocrine and clinical endpoints of exemestane as neoadjuvant therapy. Cancer Control,2002,9(2 Suppl) :9-15.
-
9Saji S, Hirose M, Toi M. Novel sensitizing agents: potential contribution of COX-2 inhibitor for endocrine therapy of breast cancer. Breast Cancer, 2004,11(2) :129-133.
-
10Chow LW, Wong JL, Toi M. Celecoxib anti-aromatase neoadjuvant(CAAN) trial for locally advanced breast cancer: preliminary report. J Steroid Biochem Mol Biol, 2003,86(3-5 ) :443-447.
共引文献76
-
1于宏,续哲莉.雌、孕激素受体在乳腺癌及增生性病变组织中的表达及意义[J].中国实验诊断学,2007,11(11):1478-1481. 被引量:6
-
2邱丽贞,续哲莉,王可人.芳香化酶抑制剂于乳腺癌新辅助治疗最新进展[J].内蒙古农业大学学报(自然科学版),2008,29(3):210-215.
-
3翟晨彤.528例乳腺癌术后行内分泌治疗的体会[J].中国实用医药,2007,2(34).
-
4Qiao-Ling Zhao1,Fen Li2,Shao-Xue Duan1,Hui-Lian Hou3 1.Department of Ultrasound,2.Maternal and Child Healthcare Center,3.Department of Pathology,the First Affiliated Hospital,Medical School of Xi’an Jiaotong University,Xi’an 710061,China.Correlation of expression of ER,PR and c-erbB-2 with ultrasonographic features in invasive ductal cancer of breast[J].Journal of Pharmaceutical Analysis,2010,22(4):273-276.
-
5胡智强,游猛.改良根治术I式治疗乳腺癌86例报告[J].中国普通外科杂志,2007,16(1):103-104. 被引量:24
-
6贺小英,韩国华.雌激素受体阳性乳腺癌术后患者化疗联合三苯氧胺与单一治疗疗效分析[J].中国煤炭工业医学杂志,2007,10(7):792-792.
-
7何劲松,袁建辉,王先明,郭良峰,朱国献,伍健春,李戎,王敏,陈伟财,吴恢升.BCSG1基因在乳腺癌新辅助化疗疗效评估中的价值[J].中国普通外科杂志,2007,16(8):793-796. 被引量:7
-
8沈克生.改良根治术Ⅰ式治疗乳腺癌68例报告[J].中国医药导报,2007,4(10S):32-33. 被引量:1
-
9朱丽英.妊娠哺乳期乳腺癌37例临床分析[J].实用肿瘤学杂志,2007,21(5):443-444. 被引量:1
-
10刘洁琼,周恩相.乳腺癌的内分泌治疗及新进展[J].医学综述,2007,13(23):1786-1788. 被引量:6
同被引文献25
-
1江泽飞,徐兵河,宋三泰,孙燕.乳腺癌内分泌治疗的基本共识[J].中华肿瘤杂志,2006,28(3):238-239. 被引量:48
-
2王丕琳,李玉文,尹子毅,张铁,朱强,智迎辉.表柔比星联合紫杉醇对浸润性乳腺癌新辅助化疗临床研究[J].中华肿瘤防治杂志,2007,14(9):698-700. 被引量:5
-
3Ellis MJ, Ma C. Letrozole in the neoadjuvant setting: the P024 trial [ J ]. Breast Cancer Res Treat, 2007, 105 (Suppl 1) :33 -43.
-
4Dixon JM, Anderson TJ, Miller WR. Neoadjuvant endocrine therapy of breast cancer : a surgical perspective [ J ]. Eur J Cancer, 2002, 38(17):2214-2221.
-
5Eiermann W, Paepke S, Appfelstaedt L, et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole : a randomized double- blind multicenter study [ J ]. Ann Oncol, 2001,12(11) :1505 -1506.
-
6Smith I, Dowstt M. Comparison of anastrozole vs tamoxifen alone and in combination as neoadjuvant treatment of estrogen receptor-positive ( ER + ) operable breast cancer in postmenopausal women : the IMPACT trial ( Abstract ) [ J ] . Breast Cancer Res Treat, 2003, 82( supple 1) : S6.
-
7Dixon JM, Love CD, Bellamy CO, et al. Letrozole as primary medical therapy for locally advanced and large operable breast cancer [ J ]. Breast Cancer Res Treat, 2001 , 66 (3) :191 -199.
-
8Ellis M J, Tao Y, Luo J, et al. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics [ J ]. J Natl Cancer Inst,2008,100(19) :1380-1388.
-
9Chung HC, Rha SY, Kim JH, et al. Pglycoprotein: the intermediate end point of drug response to induction cheroot herapy in locally advanced breast cancer [ J ]. Breast Cancer Res Treat, 1997,4 (2) :65 - 72.
-
10Bhalla K, Harris WB. Molecular and biologic determinants of neoadjuvant chemotherapy of loocoregional breast cancer [ J ] . Semin Oncol, 1998,25 ( suppl 3 ) : 19 - 24.
引证文献3
-
1张彦武,常庆龙,贾国丛.NCT不敏感的局部晚期乳腺癌的新辅助内分泌治疗疗效分析[J].中国普通外科杂志,2010,19(5):569-571. 被引量:3
-
2李庆,顾禾,付荣湛,张丽丽.NCT联合NET在绝经后乳腺癌患者中的应用[J].中国普通外科杂志,2010,19(5):576-578. 被引量:3
-
3张彦武,贾国丛,常庆龙,冯爱强.多药耐药蛋白阳性进展期乳腺癌的新辅助内分泌治疗[J].中国普通外科杂志,2011,20(5):464-466. 被引量:1
二级引证文献7
-
1管小青,吴骥,陈焰,顾书成,吴建强,吴际生,袁牧,江小玲,侍孝红,葛立峰.新辅助化疗后ER、PR由阴性转为阳性乳腺癌患者的序贯内分泌治疗[J].中国普通外科杂志,2010,19(11):1196-1199.
-
2张彦武,贾国丛,常庆龙,冯爱强.多药耐药蛋白阳性进展期乳腺癌的新辅助内分泌治疗[J].中国普通外科杂志,2011,20(5):464-466. 被引量:1
-
3刘学敏,王树生.乳腺癌MDR1基因多态性与其表达及化疗血液毒性的关系[J].中国普通外科杂志,2012,21(11):1394-1397. 被引量:2
-
4郭德阳,陈雷,王劲松,余正.芳香化酶抑制剂用于绝经后激素依赖性乳腺癌患者新辅助内分泌治疗效果的Meta分析[J].第三军医大学学报,2016,38(7):781-786. 被引量:19
-
5王海霞.术前中药联合内分泌治疗对绝经后乳腺癌患者化疗耐受性及生命质量的影响[J].辽宁中医杂志,2017,44(2):336-338. 被引量:7
-
6李天翔.内分泌联合辅助化疗治疗对乳腺癌患者临床疗效和生活质量的影响观察[J].现代诊断与治疗,2017,28(18):3348-3349. 被引量:4
-
7冷盈,刘心烛,刘佳兴,左怀全.局部晚期Luminal A型乳腺癌患者的临床病理学特征及预后分析[J].中国普外基础与临床杂志,2020,27(6):697-702. 被引量:4
-
1谢莉.辅助内分泌治疗对Ⅰ期子宫内膜癌疗效的临床观察[J].临床和实验医学杂志,2013,12(13):1063-1064. 被引量:7
-
2田丽军,徐兵河.136例大肿块女性乳腺癌的临床特点及预后分析[J].中国肿瘤临床与康复,2006,13(2):117-120. 被引量:2
-
3李丽君.辅助内分泌治疗对I期子宫内膜癌患者预后的影响[J].中国伤残医学,2014,22(13):128-128. 被引量:2
-
4谢铭,曾庆良.可手术乳腺癌三苯氧胺辅助内分泌治疗的临床观察[J].中国医师杂志,2005,7(8):1067-1067. 被引量:1
-
5王磊,赵玉沛,李丽君,陈革,廖泉.胰腺恶性内分泌肿瘤的诊治[J].中华肝胆外科杂志,2004,10(8):511-513. 被引量:3
-
6罗青.术前化疗对局部进展期胃癌患者预后影响的研究[J].安徽医药,2014,18(10):1971-1973. 被引量:4
-
7王翠琴,李桂球.老年食道癌患者围手术期的护理要点[J].黑龙江护理杂志,2000,6(2):18-19. 被引量:3
-
8预防妇科肿瘤四要点[J].家庭健康(医学科普),2015,0(9):21-21.
-
9傅小龙,将国梁,王丽娟,钱浩,傅深,叶明,赵森.局部控制在非小细胞肺癌非手术治疗中意义的探讨[J].上海医学,1996,19(10):559-562. 被引量:20
-
10张明山,于春江,孙炜,闫长祥,杨军,寸恩浩,张宏伟,宋明,任铭.鞍结节脑膜瘤术中重要结构的保护要点[J].中华神经外科杂志,2008,24(9):656-657. 被引量:11